NCT03849378

Effects of Sargassum Horneri Extract on Patients With Hypersensitivity

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: Pusan National University Yangsan Hospital · Academic / Other
• Sex: All
• Age: 12 Years – 50 Years
• Healthy volunteers: Accepted

Summary

The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Sargassum Horneri Extract in patients with skin hypersensitivity for 12 weeks.

Detailed description

Previous studies have indicated that Panax Ginseng C.A. Mey Extract may have the ability to improve liver function. Therefore, the investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of the Sargassum Horneri Extract in patients with skin hypersensitivity for 12 weeks; the safety of the compound are also evaluate. The Investigators examine SCORAD(SCORing of Atopic Dermatitis) score, PGA (Patient Global assessment) score, IGA (Investigator Global assessment) score, total IgE, eosinophil counts, ECP, IL-4, IL-31, and TARC at baseline, as well as after 6 and 12 weeks of intervention. One hundred adults were administered either 1,000 mg of Sargassum Horneri Extract or a placebo each day for 12 weeks.

Conditions

• Skin Hypersensitivity

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Sargassum Horneri Extract group	This group takes 1,000 mg/day of Sargassum Horneri Extract for 12 weeks.
DIETARY_SUPPLEMENT	Placebo group	This group takes 1,000 mg/day of Placebo Extract for 12 weeks.

Timeline

• Start date: 2019-01-01
• Primary completion: 2022-02-14
• Completion: 2022-02-28
• First posted: 2019-02-21
• Last updated: 2022-04-26

Locations

1 site across 1 country: South Korea